Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 15/20 | 0.51 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.51 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
| ▸ | RXRB | P28702 | 1/20 | 0.46 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29920978 | 0.88 | ICAM1 (0.44) | PTGER4PTGER2LTA4HKCNH2 | |
| SCHEMBL21628836 | 0.88 | ICAM1 (0.44) | PTGER4PTGER2LTA4HKCNH2 | |
| SCHEMBL21628555 | 0.87 | PTGER4 (0.44) | PTGER4PTGER2LTA4HKCNH2 | |
| SCHEMBL21628417 | 0.86 | PTGER4 (0.51) | PTGER4PTGER2LTA4HKCNH2PPARG | |
| SCHEMBL21628727 | 0.86 | PTGER4 (0.46) | PTGER4PTGER2 | |
| SCHEMBL21628630 | 0.86 | HDAC6 (0.49) | PTGER4PTGER2 | |
| SCHEMBL21628731 | 0.86 | HPGD (0.43) | PTGER4PTGER2LTA4HKCNH2 | |
| SCHEMBL21628864 | 0.85 | PTGER4 (0.47) | PTGER4PTGER2PPARG | |
| SCHEMBL21628780 | 0.85 | PTGER4 (0.44) | PTGER4PTGER2LTA4HKCNH2PPARG | |
| SCHEMBL21628788 | 0.84 | S1PR1 (0.48) | PTGER4PTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PTGER4 4387/4885PTGER2 4323/4885RXRA 684/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PTGER4 4387/4885PTGER2 4323/4885RXRA 684/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | PTGER4 4252/4885PTGER2 4166/4885RXRA 709/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PTGER4 4387/4885PTGER2 4323/4885RXRA 684/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | PTGER4 3926/4885PTGER2 3679/4885RXRA 670/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PTGER4 4387/4885PTGER2 4323/4885RXRA 684/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PTGER4 4387/4885PTGER2 4323/4885RXRA 684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.